BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11787071)

  • 1. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences.
    Kon S; Yokosaki Y; Maeda M; Segawa T; Horikoshi Y; Tsukagoshi H; Rashid MM; Morimoto J; Inobe M; Shijubo N; Chambers AF; Uede T
    J Cell Biochem; 2002; 84(2):420-32. PubMed ID: 11787071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin.
    Bautista DS; Xuan JW; Hota C; Chambers AF; Harris JF
    J Biol Chem; 1994 Sep; 269(37):23280-5. PubMed ID: 8083234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR; Perruzzi CA; Papadopoulos-Sergiou A; Van de Water L
    Mol Biol Cell; 1994 May; 5(5):565-74. PubMed ID: 7522656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of various epitopes of murine osteopontin by monoclonal antibodies.
    Hotta H; Kon S; Katagiri YU; Tosa N; Tsukamoto T; Chambers AF; Uede T
    Biochem Biophys Res Commun; 1999 Apr; 257(1):6-11. PubMed ID: 10092501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
    Bayless KJ; Davis GE
    J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.
    Katagiri YU; Murakami M; Mori K; Iizuka J; Hara T; Tanaka K; Jia WY; Chambers AF; Uede T
    J Cell Biochem; 1996 Jul; 62(1):123-31. PubMed ID: 8836881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.
    Senger DR; Perruzzi CA
    Biochim Biophys Acta; 1996 Nov; 1314(1-2):13-24. PubMed ID: 8972713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms.
    Kon S; Maeda M; Segawa T; Hagiwara Y; Horikoshi Y; Chikuma S; Tanaka K; Rashid MM; Inobe M; Chambers AF; Uede T
    J Cell Biochem; 2000 Apr; 77(3):487-98. PubMed ID: 10760956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
    Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
    PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.
    Yokosaki Y; Matsuura N; Sasaki T; Murakami I; Schneider H; Higashiyama S; Saitoh Y; Yamakido M; Taooka Y; Sheppard D
    J Biol Chem; 1999 Dec; 274(51):36328-34. PubMed ID: 10593924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration.
    Ito K; Kon S; Nakayama Y; Kurotaki D; Saito Y; Kanayama M; Kimura C; Diao H; Morimoto J; Matsui Y; Uede T
    Matrix Biol; 2009 Jan; 28(1):11-9. PubMed ID: 19000758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA; Agnihotri R; Vary CP; Liaw L
    Matrix Biol; 2004 Nov; 23(7):457-66. PubMed ID: 15579312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion.
    Xuan JW; Hota C; Chambers AF
    J Cell Biochem; 1994 Feb; 54(2):247-55. PubMed ID: 8175899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs.
    Yamaguchi Y; Hanashima S; Yagi H; Takahashi Y; Sasakawa H; Kurimoto E; Iguchi T; Kon S; Uede T; Kato K
    Biochem Biophys Res Commun; 2010 Mar; 393(3):487-91. PubMed ID: 20152802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel functional motif of osteopontin for human lymphocyte migration and survival.
    Cao Z; Dai J; Fan K; Wang H; Ji G; Li B; Zhang D; Hou S; Qian W; Zhao J; Wang H; Guo Y
    Mol Immunol; 2008 Aug; 45(14):3683-92. PubMed ID: 18632157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW; Hota C; Shigeyama Y; D'Errico JA; Somerman MJ; Chambers AF
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.
    Nishimichi N; Higashikawa F; Kinoh HH; Tateishi Y; Matsuda H; Yokosaki Y
    J Biol Chem; 2009 May; 284(22):14769-76. PubMed ID: 19346516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).
    Agnihotri R; Crawford HC; Haro H; Matrisian LM; Havrda MC; Liaw L
    J Biol Chem; 2001 Jul; 276(30):28261-7. PubMed ID: 11375993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5.
    Hu DD; Lin EC; Kovach NL; Hoyer JR; Smith JW
    J Biol Chem; 1995 Nov; 270(44):26232-8. PubMed ID: 7592829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
    Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.